The new hepatitis C virus bottleneck: Can delaying therapy be justified?

Hepatology. 2015 Sep;62(3):666-7. doi: 10.1002/hep.27931. Epub 2015 Jul 14.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents / administration & dosage*
  • Antiviral Agents / economics*
  • Drug Administration Schedule
  • Drug Costs*
  • Health Care Costs
  • Hepatitis C, Chronic / diagnosis
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / economics
  • Humans
  • Medicare / economics
  • Practice Guidelines as Topic
  • Time Factors
  • United States

Substances

  • Antiviral Agents